nefiracetam has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jorge, RE; Robinson, RG; Starkstein, SE | 1 |
| Kondoh, T; Matsuoka, T; Nishizaki, T; Nomura, T; Shiotani, T; Watabe, S; Yoshii, M | 1 |
2 review(s) available for nefiracetam and Cognition Disorders
| Article | Year |
|---|---|
Apathy following stroke.
Topics: Affective Symptoms; Brain; Brain Mapping; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Dominance, Cerebral; Humans; Motivation; Nerve Net; Nootropic Agents; Pyrrolidinones; Stroke | 2010 |
Nefiracetam. DM 9384, DZL 221, Translon.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Cognition Disorders; Humans; Pyrrolidinones | 2002 |
1 other study(ies) available for nefiracetam and Cognition Disorders
| Article | Year |
|---|---|
Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission.
Topics: Acetylcholine; Alzheimer Disease; Animals; Cognition Disorders; Electrophysiology; Glutamine; Hippocampus; Nootropic Agents; Oocytes; Protein Kinase C; Pyrrolidinones; Receptors, Nicotinic; Synaptic Transmission; Xenopus | 2000 |